SHERIDAN, WYOMING – May 7, 2025 – Baxter International Inc. (NYSE:BAX), a global leader in medical technologies, has announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. This dividend is payable on July 1, 2025, to shareholders of record as of May 30, 2025. The indicated annual dividend rate is set at $0.68 per share.
Strategic Commitment to Shareholders
As part of its ongoing commitment to delivering value to its shareholders, Baxter continues to maintain a strong dividend policy. The company’s decision to declare this quarterly cash dividend reflects both the stability of its financial performance and its dedication to providing consistent returns to its investors.
"Baxter’s ability to generate robust financial results and maintain a solid capital allocation strategy is a direct result of our continuous investments in both innovation and operational efficiency," said [Company Executive Name], [Title] of Baxter International. "We are pleased to reward our shareholders with a dependable dividend, demonstrating our commitment to both long-term growth and shareholder value."
About Baxter
Baxter International Inc. is a global medtech company whose innovative healthcare solutions play a vital role in the daily lives of millions. From diagnostic tools and critical care products to surgical and nutritional supplies, Baxter's extensive portfolio supports healthcare providers in a variety of settings, including hospitals, physician offices, and patient homes.
For over 90 years, Baxter has been at the forefront of developing life-saving and life-sustaining medical technologies. With operations spanning more than 100 countries, the company continues to build on its legacy of medical breakthroughs while advancing the next generation of transformative healthcare innovations.
Baxter's broad range of products and services help healthcare professionals improve patient outcomes and support caregivers in their mission to provide quality care. The company’s commitment to innovation ensures that it remains a trusted partner in the global healthcare sector.
Financial Outlook and Forward-Looking Statements
This dividend declaration is part of Baxter’s comprehensive capital allocation strategy, which is designed to ensure sustainable financial growth and long-term value creation. However, the company also highlights that the future dividend rate may fluctuate based on various factors, including market conditions and its ability to meet short- and long-term financial objectives.
Baxter has made clear that while it is committed to providing regular dividends, there is a possibility that future dividend payouts may differ or be suspended temporarily. Investors are encouraged to review the company’s most recent filings with the SEC for more detailed information about potential risks and factors that could impact Baxter's financial performance.
Learn More
To learn more about Baxter's commitment to healthcare innovation and shareholder value, visit www.baxter.com.